PP_1170x120_10-25-21

Biden-Harris administration

NCPA applauds Biden Administration COVID-19 strategy

NCPA applauds Biden Administration COVID-19 strategy

ALEXANDRIA, Va.  — The National Community Pharmacists Association issued the following statement from CEO B. Douglas Hoey, pharmacist, MBA, after theNational Strategy for the COVID-19 Response and Pandemic Preparedness was released by the Biden administration: “Small business neighborhood pharmacy has been engaged in the fight against the coronavirus from the start, jumping to action and installing

AAM issues statement on the Trump Administration’s “Most Favored Nation” model

AAM issues statement on the Trump Administration’s “Most Favored Nation” model

WASHINGTON — AAM and its Biosimilars Council commend the Administration for today’s effort to remove perverse rebate incentives now blocking competition in the U.S. prescription drug marketplace, but further action is necessary to modernize the Medicare Part D program and ensure that patients and taxpayers realize the full value of lower cost generic and biosimilar

AAM issues statement on 2020 election

AAM issues statement on 2020 election

WASHINGTON — The Association for Accessible Medicines’ president and CEO Dan Leonard issued the following statement on the 2020 election: “The Association for Accessible Medicines looks forward to working with the incoming Biden-Harris administration to achieve our shared goal of increasing access to safe, effective and affordable generic and biosimilar prescription medicines for all Americans.